Status:
RECRUITING
Fibromyalgia Sleep A to ZZZ Study
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is testing whether changes in sleep timing and morning light therapy may have an impact on symptoms related to fibromyalgia.
Detailed Description
This study will test a consumer health light therapy device (Re-Timer)
Eligibility Criteria
Inclusion
- Meets 2016 revised diagnostic criteria for fibromyalgia (FM)
- Has access to video conferencing (including web cameras and audio) and a private space for the remote study visits.
Exclusion
- Significant chronic disease
- Severe hearing or memory problems
- Pending medical leave applications at workplace
- Current pregnancy, breastfeeding, or actively trying to get pregnant
- Night work or travel outside the eastern time zone within 1 month of the study
- Other research participation
- Frequent number of special events during study period (weddings, concerts, exams, etc).
Key Trial Info
Start Date :
September 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2029
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT06567886
Start Date
September 27 2024
End Date
March 1 2029
Last Update
June 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48105